Drugs / Peptides (N,R&C)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01081847 Comparator | Jul 2005 → Mar 2006 | Plasmodium vivax malaria | Malaria Vaccine and Drug Development Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peptides (N,R&C) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01081847 ↗ |
| Modality | Peptide | “mixture of synthetic peptides derived from CS protein of P. vivax” NCT01081847 ↗ |
| Route | Intramuscular | “Vaccination was performed by intramuscular injection in the deltoid muscle” NCT01081847 ↗ |